ASAP1 and cancer: AMAP1 is an oncogene in various cancers, and high AMAP1 levels predict inferior outcomes in patients with triple-negative breast cancer (He et al., 2020), ovarian cancer (Hou et al., 2014), colorectal cancer (Muller et al., 2010), and laryngeal squamous cell carcinoma (Li et al., 2014).